Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikaël Thomas

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Organic & Biomolecular Chemistry|May 16, 2019
The Lossen rearrangement from free hydroxamic acidsMikaël Thomas, Jérôme Alsarraf, Nahla Araji, et al.
European Journal of Medicinal Chemistry|February 1, 2014
β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an updateIsabelle Tranoy-Opalinski, Thibaut Legigan, Romain Barat, et al.
Angewandte Chemie (International Ed. in English)|November 18, 2010
The leiodolide B puzzleAlexandre Larivée, John B Unger, Mikaël Thomas, et al.
Organic & Biomolecular Chemistry|September 24, 2013
An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification processMarion Grinda, Thibaut Legigan, Jonathan Clarhaut, et al.
European Journal of Medicinal Chemistry|July 13, 2013
Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapyThibaut Legigan, Jonathan Clarhaut, Brigitte Renoux, et al.
Angewandte Chemie (International Ed. in English)|September 22, 2012
The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapyThibaut Legigan, Jonathan Clarhaut, Isabelle Tranoy-Opalinski, et al.
Leukemia Research|June 4, 2013
A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blastsJonathan Clarhaut, Sylvain Fraineau, Joëlle Guilhot, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Organic & Biomolecular Chemistry|May 16, 2019
The Lossen rearrangement from free hydroxamic acidsMikaël Thomas, Jérôme Alsarraf, Nahla Araji, et al.
European Journal of Medicinal Chemistry|February 1, 2014
β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an updateIsabelle Tranoy-Opalinski, Thibaut Legigan, Romain Barat, et al.
Angewandte Chemie (International Ed. in English)|November 18, 2010
The leiodolide B puzzleAlexandre Larivée, John B Unger, Mikaël Thomas, et al.
Organic & Biomolecular Chemistry|September 24, 2013
An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification processMarion Grinda, Thibaut Legigan, Jonathan Clarhaut, et al.
European Journal of Medicinal Chemistry|July 13, 2013
Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapyThibaut Legigan, Jonathan Clarhaut, Brigitte Renoux, et al.
Angewandte Chemie (International Ed. in English)|September 22, 2012
The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapyThibaut Legigan, Jonathan Clarhaut, Isabelle Tranoy-Opalinski, et al.
Leukemia Research|June 4, 2013
A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blastsJonathan Clarhaut, Sylvain Fraineau, Joëlle Guilhot, et al.
Pageof 1